A dose of 40 mg once daily may be used for more severe symptoms or confirmed oesophagitis, as per clinical judgement Review at 612 weeks: Your team will assess symptom control and decide whether to continue, reduce, or stop the medication Beyond 12 weeks: Continued use only if clinically indicated for example, persistent GORD, endoscopic evidence of oesophagitis, or ongoing symptoms In line with NICE Key Therapeutic Topic KTT13 on proton pump inhibitors, the guiding principle is to use the lowest effective dose for the shortest clinically appropriate duration , with regular review and a step-down or tapering plan where possible
Seamless integration of the scheduling calendar with the clinical documentation, such as assessments, treatment plans, progress notes and insurance billing
That range is not a mistake
It activates hormone-sensitive lipase and enhances -oxidation pathways in adipocytes and muscle cells
For example, those with pernicious anemia or poor vitamin B12 absorption need a treatment plan that fits their needs